FDA regulates liquid pediatric medicines; New extended-release oral suspension antihistamine launches;

> In a guidance document, the FDA advised using flow restrictors for over-the-counter pediatric liquid drugs that contain acetaminophen. More

> FSC Pediatrics announced the launch of Karbinal ER, which it touts as the only 1st generation extended-release oral suspension antihistamine available in the U.S. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.